[HTML][HTML] Advances in molecular characterization of pediatric acute megakaryoblastic leukemia not associated with Down syndrome; impact on therapy development

J Li, ML Kalev‐Zylinska - Frontiers in Cell and Developmental Biology, 2023 - frontiersin.org
Acute megakaryoblastic leukemia (AMKL) is a rare subtype of acute myeloid leukemia
(AML) in which leukemic blasts have megakaryocytic features. AMKL makes up 4-15% of …

Clinical impact of genomic characterization of 15 patients with acute megakaryoblastic leukemia–related malignancies

E Lalonde, S Rentas, G Wertheim… - Molecular …, 2021 - molecularcasestudies.cshlp.org
Acute megakaryoblastic leukemia (AMKL) is a rare subtype of acute myeloid leukemia but is
approximately 500 times more likely to develop in children with Down syndrome (DS) …

Pediatric non–Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes

JDE De Rooij, C Branstetter, J Ma, Y Li, MP Walsh… - Nature …, 2017 - nature.com
Acute megakaryoblastic leukemia (AMKL) is a subtype of acute myeloid leukemia (AML) in
which cells morphologically resemble abnormal megakaryoblasts. While rare in adults …

The changing scenario of non-Down syndrome acute megakaryoblastic leukemia in children

R Masetti, V Guidi, L Ronchini, NS Bertuccio… - Critical reviews in …, 2019 - Elsevier
Pediatric non-Down-syndrome acute megakaryoblastic leukemia (non-DS-AMKL) is a
heterogeneous subtype of leukemia that has historically been associated with poor …

Molecular features, prognosis, and novel treatment options for pediatric acute megakaryoblastic leukemia

F De Marchi, M Araki, N Komatsu - Expert Review of Hematology, 2019 - Taylor & Francis
ABSTRACT Introduction: Acute megakaryoblastic leukemia (AMegL) is a rare hematological
neoplasm most often diagnosed in children and is commonly associated with Down's …

Pediatric acute megakaryoblastic leukemia: multitasking fusion proteins and oncogenic cooperations

CK Lopez, S Malinge, M Gaudry, OA Bernard… - Trends in Cancer, 2017 - cell.com
Pediatric leukemia presents specific clinical and genetic features from adult leukemia but the
underpinning mechanisms of transformation are still unclear. Acute megakaryoblastic …

Acute megakaryocytic leukemia

M McNulty, JD Crispino - Cold Spring …, 2020 - perspectivesinmedicine.cshlp.org
Acute megakaryoblastic leukemia (AMKL) is a rare malignancy affecting megakaryocytes,
platelet-producing cells that reside in the bone marrow. Children with Down syndrome (DS) …

The biology of pediatric acute megakaryoblastic leukemia

TA Gruber, JR Downing - Blood, The Journal of the American …, 2015 - ashpublications.org
Acute megakaryoblastic leukemia (AMKL) comprises between 4% and 15% of newly
diagnosed pediatric acute myeloid leukemia patients. AMKL in children with Down …

[HTML][HTML] A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy

AC Xavier, H Edwards, AA Dombkowski, TB Balci… - PloS one, 2011 - journals.plos.org
Background Acute megakaryocytic leukemia (AMkL) in Down syndrome (DS) children is
uniformly associated with somatic GATA1 mutations, which result in the synthesis of a …

Outcome and prognostic features in pediatric acute megakaryoblastic leukemia without down syndrome: A retrospective study in China

Y Wang, A Lu, Y Jia, Y Zuo, L Zhang - Clinical Lymphoma Myeloma and …, 2021 - Elsevier
Background Acute megakaryoblastic leukemia (AMKL) is a biologically heterogeneous
subtype of acute myeloid leukemia that originates from megakaryocytes. Patients with AMKL …